Showing results (1571-1580 of 1,742) with videos related to

Sort By:
Pageof 175
Frontiers in Immunology|September 11, 2023
Corrigendum: Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARSCoV-2 Nucleocapsid proteinLavanya Visvabharathy, Barbara A Hanson, Zachary S Orban, et al.
American Journal of Clinical Pathology|August 16, 2015
Morphologically occult systemic mastocytosis in bone marrow: clinicopathologic features and an algorithmic approach to diagnosisKaaren K Reichard, Dong Chen, Animesh Pardanani, et al.
Frontiers in Immunology|June 14, 2023
Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARS-CoV-2 Nucleocapsid proteinLavanya Visvabharathy, Barbara A Hanson, Zachary S Orban, et al.
Haematologica|June 20, 2015
Renal complications in chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis: the Mayo Clinic experiencePaolo Strati, Samih H Nasr, Nelson Leung, et al.
The New England Journal of Medicine|September 3, 2015
A Pilot Study of the Telomerase Inhibitor Imetelstat for MyelofibrosisAyalew Tefferi, Terra L Lasho, Kebede H Begna, et al.
Blood|March 16, 2013
Long-term repair of T-cell synapse activity in a phase II trial of chemoimmunotherapy followed by lenalidomide consolidation in previously untreated chronic lymphocytic leukemia (CLL)Tait D Shanafelt, Alan G Ramsay, Clive S Zent, et al.
American Journal of Hematology|September 4, 2023
A globally applicable "triple A" risk model for essential thrombocythemia based on Age, Absolute neutrophil count, and Absolute lymphocyte countAyalew Tefferi, Giuseppe G Loscocco, Faiqa Farrukh, et al.
American Journal of Hematology|November 23, 2017
Driver mutations and prognosis in primary myelofibrosis: Mayo-Careggi MPN alliance study of 1,095 patientsAyalew Tefferi, Maura Nicolosi, Mythri Mudireddy, et al.
Blood Advances|November 11, 2018
Mayo alliance prognostic system for mastocytosis: clinical and hybrid clinical-molecular modelsAnimesh Pardanani, Sahrish Shah, Francesco Mannelli, et al.
Science (New York, N.Y.)|October 27, 2007
GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor functionDaniel M Rosenbaum, Vadim Cherezov, Michael A Hanson, et al.
Pageof 175